BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 6 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,531 | -20.5% | 5,367 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $339,194 | +45.6% | 5,367 | +52.0% | 0.00% | 0.0% |
| Q3 2022 | $233,000 | -5.3% | 3,530 | -8.3% | 0.00% | 0.0% |
| Q1 2022 | $246,000 | -61.4% | 3,851 | -35.3% | 0.00% | -50.0% |
| Q4 2021 | $638,000 | +11.7% | 5,956 | +7.2% | 0.00% | 0.0% |
| Q3 2021 | $571,000 | +111.5% | 5,555 | +81.0% | 0.00% | +100.0% |
| Q2 2021 | $270,000 | -9.4% | 3,069 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $298,000 | -18.6% | 3,069 | -6.0% | 0.00% | 0.0% |
| Q4 2020 | $366,000 | – | 3,266 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |